- £81.91bn
- £95.80bn
- £32.67bn
REG - GSK PLC - Transfer of Treasury Shares
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - New Phase III Jemperli data in endometrial cancer
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Board Committee Change
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - GSK announces positive Blenrep DREAMM-8 results
AnnouncementREG - GSK PLC - ViiV LAI vs oral SOC data in adherence-challenged
AnnouncementREG - GSK PLC - GSK Annual Report 2023 on Form 20-F
AnnouncementREG - GSK PLC - New ViiV LA formulation potential 4-month dosing
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - GSK publishes Annual Report 2023
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Directorate Change
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK announces positive EAGLE-1 headline results
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - ViiV LAI superior to orals in adherence-challenged
AnnouncementREG - GSK PLC - Julie Brown - External Appointment
Announcement